Home/Filings/4/0001491519-18-000001
4//SEC Filing

Davis Chaim 4

Accession 0001491519-18-000001

CIK 0000896747other

Filed

Jun 26, 8:00 PM ET

Accepted

Jun 27, 9:58 AM ET

Size

7.2 KB

Accession

0001491519-18-000001

Insider Transaction Report

Form 4
Period: 2018-06-21
Davis Chaim
Director
Transactions
  • Award

    Common Shares

    2018-06-21$0.10/sh+33,784$3,37858,507 total
  • Other

    Non Statutory Stock Option

    2018-06-21$0.10/sh+20,000$2,00020,000 total
    Exercise: $0.10From: 2019-06-21Exp: 2028-06-21Common Shares (20,000 underlying)
Footnotes (3)
  • [F1]33,784 shares of restricted stock were issued to Davis as compensation for his attendance at a meeting of the Board of Directors held in June 2018. This stock issuance is in accordance with the director compensation structure approved by the Company's Board of Directors on March 22, 2018 (as indicated in the Company's Proxy Statement filed on April 20, 2018).
  • [F2]The closing price of the Company's common shares on June 21, 2018 was $0.10.
  • [F3]The stock option becomes 100% exercisable on June 21, 2019.

Issuer

AMERICAN BIO MEDICA CORP

CIK 0000896747

Entity typeother

Related Parties

1
  • filerCIK 0001491519

Filing Metadata

Form type
4
Filed
Jun 26, 8:00 PM ET
Accepted
Jun 27, 9:58 AM ET
Size
7.2 KB